Neoadjuvant Immunotherapy Plus Chemotherapy Shows Promise in LS-SCLC
The findings may inform future studies on the therapeutic strategy for patients with small cell lung cancer (SCLC).
Previous Post
Unrecognized Glove Perforation May Raise Infection Risk After Cesarean, reveals study
Next Post
Surprising lessons from studies about post-Katrina trauma
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago